DPMAregister | Patents - ST.27-legal status data

ST.27-legal status data

The legal status information displayed below is based on WIPO Standard ST.27 and of a purely informative nature. Binding information on the status of the IP right is only available in DPMAregister (Show details).

DE file number: 600 42 425.1, EP file number: 03 02 7484.9 (Designation/title: Verwendung von Benzodiazepinen zur Behandlung von autoimmunischen Krankheiten, Entzündungen, Neoplasien, viralen Infektionen und Atherosklerosis)

↩ Details

Tabular representation
Current state: Not active, Current state: Termination likely/termination

Key event history
No.	Key Event Code	Key Event Name	Event Date	Effective Date	Publication Date	To Stage
1	Q10	Document published	Mar 17, 2004	Mar 17, 2004		Filing
2	Q10	Document published	Mar 17, 2004	Mar 17, 2004		Filing
3	Q10	Document published	Apr 22, 2004	Apr 22, 2004	Apr 22, 2004	Filing
4	Q10	Document published	Jun 17, 2009	Jun 17, 2009		Examination
5	Q10	Document published	Jul 30, 2009	Jul 30, 2009	Jul 30, 2009	Examination
6	F10	IP right granted	Mar 17, 2010	Mar 17, 2010	Jul 8, 2010	Grant
7	H10	IP right ceased	Nov 1, 2014	Nov 1, 2014	Feb 5, 2015	Termination likely/termination

Detailed event history
No.	Detailed Event Code	Detailed Event Name	Event Date	Effective Date	Publication Date	To Stage
1	Q12	Application published	Mar 17, 2004	Mar 17, 2004		Filing
2	Q10	Document published	Mar 17, 2004	Mar 17, 2004		Filing
3	Q10	Document published	Apr 22, 2004	Apr 22, 2004	Apr 22, 2004	Filing
4	P22	Classification modified	Oct 17, 2005	Oct 17, 2005		Filing
5	Q10	Document published	Jun 17, 2009	Jun 17, 2009		Examination
6	Q10	Document published	Jul 30, 2009	Jul 30, 2009	Jul 30, 2009	Examination
7	F10	IP right granted	Mar 17, 2010	Mar 17, 2010	Jul 8, 2010	Grant
8	H13	IP right lapsed	Nov 1, 2014	Nov 1, 2014	Feb 5, 2015	Termination likely/termination

Graphical representation

Below you will see a simplified graphical representation of the legal status information, which is based on WIPO Standard ST.27 using the "Overall Patent/SPC Prosecution Model" defined therein.